Hepatitis C identification and care trends published in the December 2009 issue of Hepatology indicate a national, public health dilemma deserving of congressional action.

Scientists from Rockefeller University uncover some insights into the Hepatitis C genome that suggests new avenues for weakening this insidious virus.

A recent study revealed that a therapeutic vaccine combined with a topical immune-enhancing agent initiated an immune response against the Hepatitis C virus.

Lichen planus, a recurring skin condition that often manifests with Hepatitis C infection, can cause intense itching and pain. Learn about the skin disease's characteristics and commonly affected regions - as well as six strategies that may help reduce your

Learn about a phase II trial, whereby Boceprevir was added to standard Hepatitis C therapy (pegylated interferon and ribavirin) and was twice as effective at eliminating the Hep C virus compared to standard therapy alone.

Find out about a Henry Ford retrospective study of liver transplant recipients, which discovered that extending antiviral treatment length significantly reduced the chances of Hepatitis C recurring.

For some individuals, living with chronic hepatitis can mean having a face full of blemishes. While many feel helpless over their skin's appearance, the physiological connection between hepatitis and acne suggests that those with liver disease do have some control

In just three days of a Phase 1 trial, Idenix's experimental, nucleotide-containing Hepatitis C drug (IDX184) demonstrates excellent safety and antiviral activity.

In a large, gender comparison study, researchers found that women with Hepatitis C are more likely than men to have several disadvantages after undergoing a liver transplant.

Recent data from a Phase II trial claims that twice daily dosing of telaprevir cured Hepatitis C in over 80 participants.

Learn about the legitimate reasons to believe Hepatitis C is curable - and reasons to believe otherwise.

If choosing a doctor to help you fight the Hepatitis C virus feels overwhelming, you are not alone. To identify which physician fits your needs best, the nation's largest health insurer has developed a rating system for patients to evaluate

By expanding the applicability of cellular array technology, learn how San Diego researchers may have found a direction for the therapeutic intervention of liver fibrosis.

Repeated studies prove that those with chronic hepatitis must be evaluated directly for fibrosis progression. Although your doctor or peers may single out a normal ALT from a liver panel as good news, discover why this measurement provides little information

SciClone begins a Phase II trial to evaluate how a new drug designed to stimulate the immune system fares against Hepatitis C.

By focusing in on HCV polymerase NS5B, two companies join forces to develop new and effective medications for inhibiting the Hepatitis C virus.

Mixed cryoglobulinemia is a common extrahepatic manifestation of Hepatitis C. Although not much is known about why this vascular disease frequently accompanies the Hepatitis C virus, researchers have uncovered some new information.

Find out the strengths and weaknesses of immune globulin for preventing viral hepatitis.

Make sure you know the facts about how oral sex could transmit the three most common types of viral hepatitis. Please note: explicit descriptions of sexual activity are contained within this article.

Having an incurable disease like Hepatitis C can leave many feeling helpless over the course of their illness. However, there are many everyday choices that can either fan the flames or reduce the impact of this virus. Sugar consumption is